Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives

被引:29
作者
Liu, Haoran [1 ]
Fan, Haoqun [1 ]
Gao, Xiaohui [2 ]
Huang, Xueqing [1 ]
Liu, Xianjun [1 ]
Liu, Linbo [1 ]
Zhou, Chao [1 ]
Tang, Jingjing [1 ]
Wang, Qiuan [1 ]
Liu, Wukun [1 ]
机构
[1] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China
[2] Hunan Univ Chinese Med, Coll Pharm, Changsha, Hunan, Peoples R China
关键词
Acetylcholinesterase inhibitors; Alzheimer's disease; chalcones; structure-activity relationship; BIOACTIVE NATURAL-PRODUCTS; ALZHEIMERS-DISEASE; BIOLOGICAL EVALUATION; SIMPLIFICATION; ANALOGS; ACHE;
D O I
10.3109/14756366.2015.1050009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to study the structure-activity relationship of Flavokawain B Mannich-based derivatives as acetylcholinesterase (AChE) inhibitors in our recent investigation, 20 new nitrogen-containing chalcone derivatives (4 a-8d) were designed, synthesized, and evaluated for AChE inhibitory activity in vitro. The results suggested that amino alkyl side chain of chalcone dramatically influenced the inhibitory activity against AChE. Among them, compound 6c revealed the strongest AChE inhibitory activity (IC50 value: 0.85 mu mol/L) and the highest selectivity against AChE over BuChE (ratio: 35.79). Enzyme kinetic study showed that the inhibition mechanism of compound 6c against AChE was a mixed-type inhibition. The molecular docking assay showed that this compound can both bind with the catalytic site and the peripheral site of AChE.
引用
收藏
页码:580 / 589
页数:10
相关论文
共 21 条
[1]   Therapeutics of Alzheimer's disease: Past, present and future [J].
Anand, R. ;
Gill, Kiran Dip ;
Mahdi, Abbas Ali .
NEUROPHARMACOLOGY, 2014, 76 :27-50
[2]   Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors [J].
Asadipour, Ali ;
Alipour, Masoumeh ;
Jafari, Mona ;
Khoobi, Mehdi ;
Emami, Saeed ;
Nadri, Hamid ;
Sakhteman, Amirhossein ;
Moradi, Alireza ;
Sheibani, Vahid ;
Moghadam, Farshad Homayouni ;
Shafiee, Abbas ;
Foroumadi, Alireza .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 :623-630
[3]   Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with 'inverted' binding mode [J].
Darras, Fouad H. ;
Wehle, Sarah ;
Huang, Guozheng ;
Sotriffer, Christoph A. ;
Decker, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (17) :4867-4881
[4]   Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems [J].
Darvesh, Sultan ;
Macdonald, Ian R. ;
Martin, Earl .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (13) :3822-3825
[5]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[6]   Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: Evidence on efficacy and neurobiological correlations [J].
Garcia-Alberca, J. M. .
NEUROLOGIA, 2015, 30 (01) :8-15
[7]   Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease [J].
Gauthier, Serge ;
Molinuevo, Jose L. .
ALZHEIMERS & DEMENTIA, 2013, 9 (03) :326-331
[8]   RELATIONSHIP BETWEEN LIPOPHILIC CHARACTER AND ANESTHETIC ACTIVITY [J].
GLAVE, WR ;
HANSCH, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (04) :589-&
[9]   Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease [J].
Konrath, Eduardo Luis ;
Passos, Carolina dos Santos ;
Klein-Junior, Luiz Carlos ;
Henriques, Amelia T. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (12) :1701-1725
[10]   Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease [J].
Li, Ren-Shi ;
Wang, Xiao-Bing ;
Hu, Xiao-Jun ;
Kong, Ling-Yi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) :2636-2641